About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

26

Sep

2016

Prime Therapeutics: Processing Update for Generic Vagifem® for Covered Persons of The State of Mississippi’s State and School Employee’s Health Plan

Effective October 1st 2016

Dear Valued Provider,

On October 1, 2016, generic Vagifem (estradiol vaginal tablets) will become available to the market. Estradiol vaginal tablets will not be covered by the State of Mississippi’s State and School Employee’s Health Plan until multiple manufacturers become available or the price decreases. The innovator branded product Vagifem will continue to be covered at the same preferred brand copay of $45.

Read More...

26

Sep

2016

NCPA Advocacy Center Update 9.26.16

In this week's roundup, learn about growing support for federal DIR legislation, Congressional hearings exposing PBM tactics, and more!

Read More...

26

Sep

2016

US Script: URGENT FDA NOTICE - Sterile Products by Wells Pharmacy Network: Recall

Read More...

23

Sep

2016

US Script - Superior HealthPlan: CLINICIAN ADMINISTERED DRUGS - DO NOT AUTOREFILL

Superior HealthPlan is reminding all pharmacies that auto-refills are not allowed on Clinician Administered Drugs.1The pharmacy must contact the Provider each month, prior to dispensing any refills to ensure the patient was administered all previously dispensed medication and that the patient is still receiving treatment as previously prescribed.

Common clinician administered drugs include, but are not limited to:

  • Makena
  • Synagis
Read More...

23

Sep

2016

US Script: URGENT FDA Notice - Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall

Virtus Pharmaceuticals Opco II, LLC (Virtus) is voluntarily recalling seven batches of Hyoscyamine sulfate (0.125mg) listed in the table below, to the consumer level which include the tablet, sublingual, and orally disintegrating tablet form.

*Please see attached PDF for more information.

Read More...
First658660Last